What is Blonder Tongue's earnings per share (EPS)?

Blonder Tongue (BDRL) reported diluted earnings per share of -$0.22 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Blonder Tongue Financials

BDRL

FY2022 annual

Revenue $18.1M +15.0% YoY

Net Income -$2.9M -3576.2% YoY

EPS (Diluted) -$0.22 YoY not available

Free Cash Flow Not reported for FY2022

Source SEC Filings (10-K/10-Q) Latest period FY2022, ended Dec 31, 2022 Reported Apr 17, 2023 Currency USD FYE December

Blonder Tongue (BDRL) reported $18.1M in revenue for fiscal year 2022, up 15.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BDRL FY2022 2026-08-15

Working capital and liabilities are carrying the business while operations remain cash-negative despite a partial margin recovery.

From the prior year, operating margin improved to -11.8%, yet operating cash flow still ran at -$1.4M, so better accounting performance did not translate into self-financing operations. Cash at $79K and debt-to-equity at 13.0x show that the repair was funded by stretching the balance sheet rather than by cash generated inside the business.

Liquidity is tied up in working capital, not in cash: inventory plus receivables were about $7.4M against only $79K of cash. That makes day-to-day flexibility depend on turning stock into sales and collecting customers on time, and the sub-1.0 current ratio leaves little room for slippage.

The business shows a gross-to-operating gap: gross margin was 30.2% in the latest year, but net margin was -16.1% after overhead and financing costs. With a thin equity base of $1.1M against liabilities of $13.9M, leverage is now highly sensitive to additional losses or working-capital swings.

Financial Health Signals

Financial health score not available

Blonder Tongue does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-2.09

Blonder Tongue scores -2.09, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($260K) relative to total liabilities ($13.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

1/8

Blonder Tongue passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Blonder Tongue reported a net loss of $2.9M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Blonder Tongue reported an operating loss of $2.1M against $789K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$18.1M

YoY+15.0%

5Y CAGR-4.9%

10Y CAGR-5.1%

Blonder Tongue generated $18.1M in revenue in fiscal year 2022. This represents an increase of 15.0% from the prior year.

EBITDA

-$2.0M

YoY+28.7%

Blonder Tongue's EBITDA was -$2.0M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 28.7% from the prior year.

Net Income

-$2.9M

YoY-3576.2%

Blonder Tongue reported -$2.9M in net income in fiscal year 2022. This represents a decrease of 3576.2% from the prior year.

EPS (Diluted)

-$0.22

Blonder Tongue earned -$0.22 per diluted share (EPS) in fiscal year 2022.

Cash & Balance Sheet

Cash & Debt

$79K

YoY-71.2%

5Y CAGR-14.0%

10Y CAGR-16.0%

Blonder Tongue held $79K in cash as of fiscal year 2022; long-term debt is not reported for that period.

Shares Outstanding

13M

Blonder Tongue had 13M shares outstanding in fiscal year 2022.

Free Cash Flow

Not reported for fiscal year 2022.

Dividends Per Share

Not reported for fiscal year 2022.

Margins & Returns

Gross Margin

30.2%

YoY-7.0pp

5Y CAGR-8.2pp

10Y CAGR-2.5pp

Blonder Tongue's gross margin was 30.2% in fiscal year 2022, indicating the percentage of revenue retained after direct costs. This is down 7.0 percentage points from the prior year.

Operating Margin

-11.8%

YoY+7.0pp

5Y CAGR-13.8pp

10Y CAGR-3.6pp

Blonder Tongue's operating margin was -11.8% in fiscal year 2022, reflecting core business profitability. This is up 7.0 percentage points from the prior year.

Net Margin

-16.1%

YoY-16.7pp

5Y CAGR-14.5pp

10Y CAGR+0.7pp

Blonder Tongue's net profit margin was -16.1% in fiscal year 2022, showing the share of revenue converted to profit. This is down 16.7 percentage points from the prior year.

Return on Equity

-271.9%

YoY-274.4pp

5Y CAGR-266.7pp

10Y CAGR-240.9pp

Blonder Tongue's ROE was -271.9% in fiscal year 2022, measuring profit generated per dollar of shareholder equity. This is down 274.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$1.8M

YoY-31.4%

5Y CAGR-6.2%

10Y CAGR-6.5%

Blonder Tongue invested $1.8M in research and development in fiscal year 2022. This represents a decrease of 31.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2022.

Capital Expenditures

Not reported for fiscal year 2022.

BDRL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BDRL quarterly income statement

Metric	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Revenue	$18.1M+15.0%	$15.8M-3.8%	$16.4M-17.5%	$19.8M-8.6%	$21.7M-6.8%	$23.3M+3.5%	$22.5M+7.5%	$20.9M-28.1%	$29.1M+4.5%	$27.9M-9.0%	$30.6M+14.9%	$26.7M-12.6%	$30.5M
Cost of Revenue	$40K-4.8%	$42K-99.7%	$13.4M-18.6%	$16.4M+23.5%	$13.3M-7.4%	$14.3M+1.4%	$14.1M-15.7%	$16.8M-7.6%	$18.2M-2.1%	$18.6M-10.0%	$20.6M+20.5%	$17.1M-6.1%	$18.2M
Gross Profit	$5.5M-6.7%	$5.9M+94.1%	$3.0M-12.0%	$3.4M-59.2%	$8.4M-5.8%	$8.9M+6.9%	$8.4M+101.1%	$4.2M-62.1%	$11.0M+17.7%	$9.3M-7.1%	$10.0M+5.0%	$9.5M-22.2%	$12.3M
R&D Expenses	$1.8M-31.4%	$2.6M+2.7%	$2.5M-17.7%	$3.1M+19.0%	$2.6M+5.1%	$2.5M-10.5%	$2.7M-17.7%	$3.3M-2.5%	$3.4M+1.3%	$3.4M-3.6%	$3.5M+28.9%	$2.7M+8.3%	$2.5M
SG&A Expenses	$3.8M+1.4%	$3.8M-26.9%	$5.2M+2.9%	$5.0M+18.1%	$4.2M+20.0%	$3.5M-7.8%	$3.8M-7.8%	$4.2M-13.0%	$4.8M-6.7%	$5.1M-9.3%	$5.6M+27.8%	$4.4M-4.1%	$4.6M
Operating Income	-$2.1M+28.0%	-$3.0M+58.4%	-$7.1M-1426.6%	-$466K+45.4%	-$854K-284.4%	$463K+169.0%	-$671K+89.5%	-$6.4M-917.5%	-$629K+75.3%	-$2.5M-2.0%	-$2.5M-966.2%	-$234K-111.8%	$2.0M
Interest Expense	$789K+53.5%	$514K+49.0%	$345K+32.2%	$261K-53.6%	$562K-22.3%	$723K+75.5%	$412K+26.8%	$325K+34.3%	$242K-12.6%	$277K-16.1%	$330K+80.3%	$183K-8.0%	$199K
Income Tax	N/A	$15K0.0%	$15K0.0%	$15K+119.5%	-$77K-327.8%	-$18K-162.1%	$29K-37.0%	$46K+48.4%	$31K	$0-100.0%	$2.3M	$0	$0
Net Income	-$2.9M-3576.2%	$84K+101.1%	-$7.5M-907.3%	-$742K+44.6%	-$1.3M-248.7%	-$384K+67.9%	-$1.2M+82.4%	-$6.8M-650.7%	-$902K+68.0%	-$2.8M+45.3%	-$5.2M-1154.7%	-$411K-123.0%	$1.8M
EPS (Diluted)	-$0.22	$0.02	-$0.76	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.07-125.0%	$0.28

Metric	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21
Revenue	$5.3M+0.3%	$5.3M+24.3%	$4.2M+26.7%	$3.3M-16.3%	$4.0M-4.3%	$4.2M-3.8%	$4.3M+33.4%	$3.3M
Cost of Revenue	-$9.4M-343.6%	$3.9M+21.4%	$3.2M+32.1%	$2.4M+133.2%	-$7.2M-370.5%	$2.7M-2.2%	$2.7M+46.5%	$1.9M
Gross Profit	$2.1M+46.0%	$1.4M+32.8%	$1.1M+12.9%	$939K-31.4%	$1.4M-8.7%	$1.5M-6.6%	$1.6M+15.9%	$1.4M
R&D Expenses	$357K-6.5%	$382K-23.3%	$498K-7.9%	$541K-19.4%	$671K+1.7%	$660K+5.9%	$623K-2.4%	$638K
SG&A Expenses	$895K-12.3%	$1.0M+2.7%	$993K+8.8%	$913K+10.9%	$823K-8.6%	$900K-6.7%	$965K-10.6%	$1.1M
Operating Income	N/A	-$475K+50.6%	-$962K	N/A	-$777K-10.5%	-$703K-13.9%	-$617K+28.5%	-$863K
Interest Expense	$236K+3.5%	$228K+18.8%	$192K+44.4%	$133K-1.5%	$135K+15.4%	$117K-12.7%	$134K+4.7%	$128K
Net Income	$90K+112.8%	-$703K+39.0%	-$1.2M+0.1%	-$1.2M-24.5%	-$927K-361.2%	-$201K-112.4%	$1.6M+492.8%	-$414K
EPS (Diluted)	$0.01	-$0.05+44.4%	-$0.090.0%	-$0.09-50.0%	-$0.06	-$0.02-118.2%	$0.11+375.0%	-$0.04

Not reported in any period shown, so not listed: Income Tax.

BDRL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BDRL quarterly balance sheet

Metric	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Total Assets	$15.0M+26.0%	$11.9M+7.0%	$11.1M-39.3%	$18.3M+17.6%	$15.6M+2.8%	$15.2M+1.2%	$15.0M-7.6%	$16.2M-23.6%	$21.2M-6.2%	$22.6M-13.9%	$26.3M+1.7%	$25.9M-2.8%	$26.6M
Current Assets	$8.0M+3.8%	$7.7M+25.8%	$6.1M-49.9%	$12.2M+17.3%	$10.4M+15.9%	$8.9M+10.8%	$8.1M-2.8%	$8.3M-33.8%	$12.6M-4.5%	$13.2M-17.5%	$16.0M+16.6%	$13.7M-1.4%	$13.9M
Cash & Equivalents	$79K-71.2%	$274K+297.1%	$69K-87.9%	$572K+2.3%	$559K+232.7%	$168K-64.1%	$468K+5100.0%	$9K-96.1%	$232K+246.3%	$67K-85.2%	$453K-46.8%	$851K-50.4%	$1.7M
Inventory	$4.0M-18.3%	$4.9M+19.5%	$4.1M-52.1%	$8.5M+37.5%	$6.2M+12.3%	$5.5M+8.5%	$5.1M-9.5%	$5.6M-39.6%	$9.3M+3.1%	$9.0M-20.7%	$11.3M+49.6%	$7.6M-1.4%	$7.7M
Accounts Receivable	$3.4M+92.0%	$1.8M+1.4%	$1.7M-30.5%	$2.5M-5.6%	$2.7M+1.3%	$2.6M+15.3%	$2.3M-6.5%	$2.4M+0.3%	$2.4M-25.2%	$3.2M-6.4%	$3.5M-22.8%	$4.5M+22.0%	$3.7M
Goodwill	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K	$0	N/A
Total Liabilities	$13.9M+61.5%	$8.6M-12.8%	$9.9M-9.9%	$11.0M+30.2%	$8.4M+8.7%	$7.8M-8.3%	$8.5M-4.5%	$8.9M+18.1%	$7.5M-1.4%	$7.6M-21.3%	$9.7M+107.3%	$4.7M+2.2%	$4.6M
Current Liabilities	$8.2M+34.6%	$6.1M+9.5%	$5.5M-33.9%	$8.4M+1.3%	$8.3M+109.8%	$3.9M-14.7%	$4.6M-46.5%	$8.6M+126.7%	$3.8M+4.0%	$3.7M-33.3%	$5.5M+197.0%	$1.8M+8.8%	$1.7M
Long-Term Debt	N/A	N/A	$1.8M+3723.4%	$47K+46.9%	$32K-99.0%	$3.1M-7.2%	$3.3M+33250.0%	$10K-99.7%	$3.6M-7.3%	$3.9M-6.5%	$4.2M+47.6%	$2.8M-1.8%	$2.9M
Total Equity	$1.1M-67.3%	$3.3M+165.6%	$1.2M-83.2%	$7.4M+2.7%	$7.2M-3.3%	$7.4M+13.5%	$6.5M-11.3%	$7.4M-46.4%	$13.7M-8.6%	$15.0M-9.6%	$16.6M-21.6%	$21.2M-3.8%	$22.0M
Retained Earnings	-$30.2M-10.7%	-$27.3M+0.3%	-$27.4M-37.5%	-$19.9M-3.9%	-$19.2M-7.6%	-$17.8M-3.7%	-$17.2M-40.8%	-$12.2M-197.8%	-$4.1M-28.2%	-$3.2M-758.6%	-$372K-107.8%	$4.8M-7.9%	$5.2M

Metric	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21
Total Assets	$15.0M-1.8%	$15.3M+24.2%	$12.3M+6.6%	$11.5M-3.2%	$11.9M-1.8%	$12.1M+1.9%	$11.9M+7.1%	$11.1M
Current Assets	$8.0M-3.2%	$8.2M-4.1%	$8.6M+13.9%	$7.5M-1.8%	$7.7M+0.5%	$7.6M+7.4%	$7.1M+11.9%	$6.4M
Cash & Equivalents	$79K-52.7%	$167K-53.7%	$361K+228.2%	$110K-59.9%	$274K+1.1%	$271K-21.2%	$344K+514.3%	$56K
Inventory	$4.0M-4.6%	$4.2M-16.3%	$5.0M0.0%	$5.0M+2.3%	$4.9M+18.9%	$4.1M+8.1%	$3.8M-6.6%	$4.0M
Accounts Receivable	$3.4M+7.5%	$3.2M+28.3%	$2.5M+77.4%	$1.4M-21.5%	$1.8M-0.3%	$1.8M-2.7%	$1.8M+69.5%	$1.1M
Goodwill	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K
Total Liabilities	$13.9M-2.9%	$14.3M+32.4%	$10.8M+18.7%	$9.1M+5.8%	$8.6M+3.0%	$8.4M-0.5%	$8.4M-12.5%	$9.6M
Current Liabilities	$8.2M-3.7%	$8.5M-2.6%	$8.7M+27.8%	$6.8M+12.2%	$6.1M+7.4%	$5.6M+2.3%	$5.5M+11.0%	$5.0M
Total Equity	$1.1M+14.6%	$937K-36.2%	$1.5M-39.1%	$2.4M-26.6%	$3.3M-12.5%	$3.8M+7.6%	$3.5M+131.9%	$1.5M
Retained Earnings	-$30.2M+0.3%	-$30.3M-2.4%	-$29.6M-4.1%	-$28.5M-4.2%	-$27.3M-3.5%	-$26.4M-0.8%	-$26.2M+5.8%	-$27.8M

Not reported in any period shown, so not listed: Long-Term Debt.

BDRL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BDRL quarterly cash flow statement

Metric	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Operating Cash Flow	-$1.4M-18.4%	-$1.2M+63.7%	-$3.2M+50.9%	-$6.5M-1213.8%	$587K+347.7%	-$237K-130.7%	$771K+196.6%	-$798K-149.4%	$1.6M-13.2%	$1.9M-48.9%	$3.6M+1423.0%	$239K-92.2%	$3.1M
Capital Expenditures	N/A	$31K-81.2%	$165K-37.3%	$263K+224.7%	$81K-41.3%	$138K+273.0%	$37K-80.3%	$188K-72.1%	$673K+337.0%	$154K+51.0%	$102K-49.0%	$200K+70.9%	$117K
Free Cash Flow	N/A	-$1.2M+64.5%	-$3.4M+50.3%	-$6.8M-1444.1%	$506K+234.9%	-$375K-151.1%	$734K+174.4%	-$986K-204.7%	$942K-44.8%	$1.7M-51.8%	$3.5M+8971.8%	$39K-98.7%	$3.0M
Investing Cash Flow	-$55K+36.0%	-$86K+55.0%	-$191K-102.0%	$9.5M+9480.2%	-$101K+49.5%	-$200K	N/A	N/A	N/A	N/A	-$7.6M-767.9%	-$872K+23.5%	-$1.1M
Financing Cash Flow	$1.2M-14.8%	$1.5M-49.7%	$2.9M+199.2%	-$2.9M-2976.8%	-$95K-169.3%	$137K	N/A	N/A	N/A	N/A	$3.5M+1615.0%	-$233K-2.2%	-$228K

Metric	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21
Operating Cash Flow	$210K+195.5%	-$220K+84.8%	-$1.4M-1959.0%	$78K+114.4%	-$540K+28.3%	-$753K-597.2%	-$108K-146.2%	$234K
Capital Expenditures	N/A	N/A	N/A	N/A	$19K+375.0%	$4K	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	-$559K+26.2%	-$757K	N/A	N/A
Investing Cash Flow	-$13K+27.8%	-$18K+10.0%	-$20K-400.0%	-$4K+78.9%	-$19K-375.0%	-$4K+85.2%	-$27K+25.0%	-$36K
Financing Cash Flow	-$285K-747.7%	$44K-97.4%	$1.7M+823.1%	-$238K-142.3%	$562K-17.8%	$684K+61.7%	$423K+300.5%	-$211K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BDRL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

BDRL quarterly financial ratios

Metric	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Gross Margin	30.2%-7.0pp	37.2%+18.8pp	18.4%+1.1pp	17.3%-21.5pp	38.8%+0.4pp	38.4%+1.2pp	37.1%+17.3pp	19.8%-17.8pp	37.6%+4.2pp	33.4%+0.7pp	32.7%-3.1pp	35.8%-4.4pp	40.2%
Operating Margin	-11.8%+7.0pp	-18.8%+24.6pp	-43.4%-41.1pp	-2.4%+1.6pp	-3.9%-5.9pp	2.0%+5.0pp	-3.0%+27.6pp	-30.6%-28.4pp	-2.2%+7.0pp	-9.1%-1.0pp	-8.1%-7.3pp	-0.9%-7.4pp	6.5%
Net Margin	-16.1%-16.7pp	0.5%+46.2pp	-45.6%-41.9pp	-3.7%+2.4pp	-6.2%-4.5pp	-1.7%+3.7pp	-5.3%+27.0pp	-32.3%-29.2pp	-3.1%+7.0pp	-10.1%+6.7pp	-16.8%-15.3pp	-1.5%-7.4pp	5.9%
Return on Equity	-271.9%-274.4pp	2.6%+606.8pp	-604.2%-594.1pp	-10.1%+8.6pp	-18.7%-13.5pp	-5.2%+13.1pp	-18.3%+73.6pp	-91.9%-85.3pp	-6.6%+12.2pp	-18.8%+12.2pp	-31.0%-29.1pp	-1.9%-10.0pp	8.1%
Return on Assets	-19.5%-20.2pp	0.7%+67.9pp	-67.2%-63.1pp	-4.0%+4.5pp	-8.6%-6.0pp	-2.5%+5.4pp	-8.0%+33.8pp	-41.7%-37.5pp	-4.3%+8.2pp	-12.5%+7.1pp	-19.6%-18.0pp	-1.6%-8.3pp	6.7%
Current Ratio	0.98-0.3x	1.27+0.2x	1.10-0.4x	1.45+0.2x	1.26-1.0x	2.27+0.5x	1.75+0.8x	0.96-2.3x	3.30-0.3x	3.60+0.7x	2.91-4.5x	7.41-0.8x	8.18
Debt-to-Equity	12.97+10.3x	2.63+1.2x	1.45+1.4x	0.010.0x	0.00-0.4x	0.42-0.1x	0.51+0.5x	0.00-0.3x	0.260.0x	0.260.0x	0.25+0.1x	0.130.0x	0.13
FCF Margin	N/A	-7.6%+13.0pp	-20.6%+13.7pp	-34.3%-36.6pp	2.3%+3.9pp	-1.6%-4.9pp	3.3%+8.0pp	-4.7%-7.9pp	3.2%-2.9pp	6.1%-5.4pp	11.6%+11.4pp	0.1%-9.5pp	9.7%

Metric	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21
Gross Margin	39.0%+12.2pp	26.8%+1.7pp	25.0%-3.1pp	28.1%-6.2pp	34.3%-1.7pp	35.9%-1.1pp	37.0%-5.6pp	42.6%
Operating Margin	N/A	-9.0%+13.7pp	-22.7%	N/A	-19.5%-2.6pp	-16.9%-2.6pp	-14.2%+12.3pp	-26.6%
Net Margin	1.7%+15.1pp	-13.4%+13.9pp	-27.2%+7.3pp	-34.5%-11.3pp	-23.2%-18.4pp	-4.8%-42.3pp	37.5%+50.2pp	-12.7%
Return on Equity	8.4%+83.4pp	-75.0%+3.5pp	-78.5%-30.7pp	-47.9%-19.6pp	-28.2%-22.9pp	-5.3%-51.9pp	46.6%+74.1pp	-27.5%
Return on Assets	0.6%+5.2pp	-4.6%+4.8pp	-9.4%+0.6pp	-10.0%-2.2pp	-7.8%-6.1pp	-1.7%-15.3pp	13.7%+17.4pp	-3.7%
Current Ratio	0.980.0x	0.970.0x	0.99-0.1x	1.11-0.2x	1.27-0.1x	1.35+0.1x	1.290.0x	1.28
Debt-to-Equity	12.97-2.3x	15.31+7.9x	7.38+3.6x	3.78+1.2x	2.63+0.4x	2.23-0.2x	2.41-4.0x	6.39
FCF Margin	N/A	N/A	N/A	N/A	-14.0%+4.1pp	-18.1%	N/A	N/A

Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

$736K

$185K

$15.1M

$11.9M

Novra Technologi NVRVF

$4.6M

Where Blonder Tongue Ranks

Frequently Asked Questions

What is Blonder Tongue's annual revenue?

Blonder Tongue (BDRL) reported $18.1M in total revenue for fiscal year 2022. This represents a 15.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Blonder Tongue's revenue growing?

Blonder Tongue (BDRL) revenue grew by 15.0% year-over-year, from $15.8M to $18.1M in fiscal year 2022.

Is Blonder Tongue profitable?

No, Blonder Tongue (BDRL) reported a net income of -$2.9M in fiscal year 2022, with a net profit margin of -16.1%.

What is Blonder Tongue's EBITDA?

Blonder Tongue (BDRL) had EBITDA of -$2.0M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.

What is Blonder Tongue's gross margin?

Blonder Tongue (BDRL) had a gross margin of 30.2% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.

What is Blonder Tongue's operating margin?

Blonder Tongue (BDRL) had an operating margin of -11.8% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

What is Blonder Tongue's net profit margin?

Blonder Tongue (BDRL) had a net profit margin of -16.1% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.

What is Blonder Tongue's return on equity (ROE)?

Blonder Tongue (BDRL) has a return on equity of -271.9% for fiscal year 2022, measuring how efficiently the company generates profit from shareholder equity.

What is Blonder Tongue's operating cash flow?

Blonder Tongue (BDRL) recorded an outflow of $1.4M in operating cash flow during fiscal year 2022, representing cash used by core business activities.

What are Blonder Tongue's total assets?

Blonder Tongue (BDRL) had $15.0M in total assets as of fiscal year 2022, including both current and long-term assets.

How much does Blonder Tongue spend on research and development?

Blonder Tongue (BDRL) invested $1.8M in research and development during fiscal year 2022.

How many shares does Blonder Tongue have outstanding?

Blonder Tongue (BDRL) had 13M shares outstanding as of fiscal year 2022.

What is Blonder Tongue's current ratio?

Blonder Tongue (BDRL) had a current ratio of 0.98 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.

What is Blonder Tongue's debt-to-equity ratio?

Blonder Tongue (BDRL) had a debt-to-equity ratio of 12.97 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Blonder Tongue's return on assets (ROA)?

Blonder Tongue (BDRL) had a return on assets of -19.5% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.

How does Blonder Tongue's liquidity compare with its operating cash outflow?

At the end of fiscal year 2022, Blonder Tongue (BDRL) held $79K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.4M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Blonder Tongue's Altman Z-Score?

Blonder Tongue (BDRL) has an Altman Z-Score of -2.09, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Blonder Tongue's Piotroski F-Score?

Blonder Tongue (BDRL) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Blonder Tongue's earnings high quality?

Blonder Tongue (BDRL) reported a net loss of $2.9M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Blonder Tongue cover its interest payments?

Blonder Tongue (BDRL) reported an operating loss of $2.1M against $789K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.